Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

This summary is generated by an algorithm. If you find any mistakes, let us know.

Orchard Raises $100 Million Series D, Achieves Unicorn Status
Orchard Raises $100 Million Series D, Achieves Unicorn Status
UN

Unicorn Nest news

Orchard Raises $100 Million Series D, Achieves Unicorn Status

– Orchard, the company that is radically simplifying home buying and selling, announced today that it has raised $100 million in Series D funding at over a $1 billion valuation.
Accomplice led the round with participation from repeat investors FirstMark, Revolution, First American, Juxtapose and a syndicate of new investors.
– This new round of equity funding will support Orchard’s continued growth and innovation.

Source
86 Repairs Raises $5.3M in Funding
86 Repairs Raises $5.3M in Funding
UN

Unicorn Nest news

86 Repairs Raises $5.3M in Funding

– 86 Repairs is a platform that automates the end-to-end repair and maintenance process for restaurants, providing actionable insights to improve back-of-house operations.
– The company received $7.3m in Series A funding.
– The round was led by TDF Ventures, Gordon Food Service (GFS), MATH Venture Partners, Revolution, and Cleveland Avenue.
– The new investment will be used to scale up product innovations and accelerate growth.

Source
Bionaut Labs Emerges From Stealth With $20M
Bionaut Labs Emerges From Stealth With $20M
UN

Unicorn Nest news

Bionaut Labs Emerges From Stealth With $20M

– Bionaut Labs, a company focused on Revolutionizing the treatment of central nervous system disorders (CNS) with its Bionaut™ precision medicine treatment modality, today announced its launch backed by $20m financing led by Khosla Ventures.
– Other investors in the syndicate included Upfront Ventures, Revolution, BOLD Capital, and Compound.
– Proceeds from the financing support the advancement of the Company’s lead therapeutic program in glioma through preclinical development.

Source
1 2 3 58 59 60
Crunchbase icon

Content report

The following text will be sent to our editors: